Structural biology and public health response to biomedical threats

Struct Dyn. 2023 Jun 5;10(3):034701. doi: 10.1063/4.0000186. eCollection 2023 May.

Abstract

Over the course of the pandemic caused by SARS-CoV-2, structural biologists have worked hand in hand with groups developing vaccines and treatments. However, relying solely on in vitro and clinical studies may be insufficient to guide vaccination and treatment developments, and other healthcare policies during virus mutations or peaks in infections and fatalities. Therefore, it is crucial to track statistical data related to the number of infections, deaths, and vaccinations in specific regions and present it in an easy-to-understand way.